Augmedics
Private Company
Total funding raised: $126.8M
Overview
Augmedics is a pioneer in augmented reality surgical navigation, specifically targeting the complex spine surgery market. The company's xvision Spine System, which received FDA clearance in 2019, allows surgeons to see through tissue by projecting CT-based 3D anatomical structures onto their retina in real-time, aiming to improve surgical accuracy and reduce reliance on traditional monitors. As a private company founded in 2014 and headquartered in Chicago, it has secured significant venture funding to commercialize its technology and expand its platform. Its value proposition centers on improving surgical outcomes, reducing radiation exposure, and increasing operating room efficiency.
Technology Platform
Augmented Reality (AR) surgical navigation platform featuring a head-mounted display that projects 3D CT-based anatomical visualizations and surgical plans directly into the surgeon's field of view in real-time.
Funding History
3Opportunities
Risk Factors
Competitive Landscape
Augmedics competes in the surgical navigation market against giants like Medtronic (Mazor robotics and StealthStation navigation), Stryker (Mako for spine and Q guidance), and Globus Medical (ExcelsiusGPS). It differentiates through its head-mounted AR interface, offering a hands-free, in-situ visualization alternative to traditional monitor-based navigation systems. It also competes indirectly with fluoroscopy-based techniques and other emerging AR/VR surgical startups.